Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Cormican

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Irish Journal of Medical Science|March 1, 1992
Tuberculosis in the west of Ireland 1986-1990M G Cormican, J Flynn
Diagnostic Microbiology and Infectious Disease|May 1, 1995
Antimicrobial activity of cefotaxime tested against infrequently isolated pathogenic species (unusual pathogens)M G Cormican, R N Jones
The Journal of Antimicrobial Chemotherapy|April 1, 1995
Evaluation of the in-vitro activity of furopenem (SY5555 or SUN5555) against respiratory tract pathogens and beta-lactamase producing bacteriaM G Cormican, R N Jones
Journal of Clinical Microbiology|August 1, 1995
Use of a multiplex PCR to detect and identify Mycobacterium avium and M. intracellulare in blood culture fluids of AIDS patientsM G Cormican, R N Jones
Drugs|January 1, 1996
Emerging resistance to antimicrobial agents in gram-positive bacteria. Enterococci, staphylococci and nonpneumococcal streptococciM G Cormican, R N Jones
Diagnostic Microbiology and Infectious Disease|April 1, 1995
Reevaluations of disk diffusion susceptibility testing interpretive criteria for lomefloxacin and norfloxacin using fluoroquinolone-resistant isolatesM G Cormican, R N Jones
The Journal of Antimicrobial Chemotherapy|October 1, 1996
Standardization of antifungal susceptibility testingM G Cormican, M A Pfaller
The Journal of Antimicrobial Chemotherapy|August 1, 1995
Cross-resistance analysis for clinafloxacin compared with ciprofloxacin, fleroxacin, ofloxacin, and sparfloxacin using a predictor panel of ciprofloxacin-resistant bacteriaM G Cormican, R N Jones
Journal of Clinical Microbiology|January 1, 1995
Susceptibility to levofloxacin predicted from in vitro susceptibility testing results obtained with ciprofloxacin and with ofloxacinM G Cormican, R N Jones
Antimicrobial Agents and Chemotherapy|January 1, 1997
Antimicrobial activity and spectrum of LB20304, a novel fluoronaphthyridoneM G Cormican, R N Jones
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Irish Journal of Medical Science|March 1, 1992
Tuberculosis in the west of Ireland 1986-1990M G Cormican, J Flynn
Diagnostic Microbiology and Infectious Disease|May 1, 1995
Antimicrobial activity of cefotaxime tested against infrequently isolated pathogenic species (unusual pathogens)M G Cormican, R N Jones
The Journal of Antimicrobial Chemotherapy|April 1, 1995
Evaluation of the in-vitro activity of furopenem (SY5555 or SUN5555) against respiratory tract pathogens and beta-lactamase producing bacteriaM G Cormican, R N Jones
Journal of Clinical Microbiology|August 1, 1995
Use of a multiplex PCR to detect and identify Mycobacterium avium and M. intracellulare in blood culture fluids of AIDS patientsM G Cormican, R N Jones
Drugs|January 1, 1996
Emerging resistance to antimicrobial agents in gram-positive bacteria. Enterococci, staphylococci and nonpneumococcal streptococciM G Cormican, R N Jones
Diagnostic Microbiology and Infectious Disease|April 1, 1995
Reevaluations of disk diffusion susceptibility testing interpretive criteria for lomefloxacin and norfloxacin using fluoroquinolone-resistant isolatesM G Cormican, R N Jones
The Journal of Antimicrobial Chemotherapy|October 1, 1996
Standardization of antifungal susceptibility testingM G Cormican, M A Pfaller
The Journal of Antimicrobial Chemotherapy|August 1, 1995
Cross-resistance analysis for clinafloxacin compared with ciprofloxacin, fleroxacin, ofloxacin, and sparfloxacin using a predictor panel of ciprofloxacin-resistant bacteriaM G Cormican, R N Jones
Journal of Clinical Microbiology|January 1, 1995
Susceptibility to levofloxacin predicted from in vitro susceptibility testing results obtained with ciprofloxacin and with ofloxacinM G Cormican, R N Jones
Antimicrobial Agents and Chemotherapy|January 1, 1997
Antimicrobial activity and spectrum of LB20304, a novel fluoronaphthyridoneM G Cormican, R N Jones
Pageof 4